April 2, 2021 COVID-19 vaccines open to 16-year-olds in these 20 states, 18 more next week People who are 16-years-old or older can officially get their COVID-19 vaccines in 30 states starting next week.
April 2, 2021 Seattle homeless getting vaccinations and FEMA funded hotels Homeless people in Seattle are now getting their Covid vaccination shots, yet the city is expanding its use of a federal program that pays to house homeless individuals in hotels.
April 2, 2021 Vermont GOP governor opens up COVID vaccines for those who identify as Black, Indigenous or person of color Vermont is opening up coronavirus vaccine eligiblity to anyone over 16 years of age who identifies as Black, Indigenous or a person of color — prompting fierce criticism online for excluding White people.
April 2, 2021 Johnson & Johnson COVID-19 vaccine production blunder doesn’t impact distributed doses, White House says The production error that occurred at Emergent BioSolutions and saw millions of the Johnson & Johnson COVID-19 vaccine discarded does not impact already distributed doses, the White House said on Friday.
April 2, 2021 FDA updates Moderna COVID-19 vaccine EUA in bid to speed rollout The FDA announced two revisions to the emergency use authorization (EUA) granted to Moderna’s COVID-19 vaccine in the hopes that it will help expedite the rollout.
April 1, 2021 UK 'focus on first doses' of vaccine helping them control pandemic quicker than US: Dr. Makary The U.S. should take a page from the United Kingdom's coronavirus vaccination strategy, ӣƵ medical contributor Dr. Marty Makary told Fox Business Network's "Kudlow" Thursday.
April 1, 2021 Biden supports vaccines for undocumented immigrants: Psaki White House press secretary Jen Psaki said during Thursday's press briefing that President Biden supports coronavirus vaccines for undocumented immigrants.
April 1, 2021 Can I still spread the coronavirus after I'm vaccinated? Can I still spread the coronavirus after I’m vaccinated?
April 1, 2021 Pfizer COVID-19 vaccine protects against South African variant, lasts 6 months, data shows The COVID-19 vaccine developed by Pfizer and partnering biotechnology company BioNTech has proven “highly effective” against the coronavirus — including variants — for at least six months after full inoculation.
April 1, 2021 Early trials for Moderna’s COVID-19 vaccine against South African variant begin, NIH says The National Institutes of Health has officially begun early-stage trials of an investigational COVID-19 vaccine developed by Moderna to protect against a concerning coronavirus variant that was first identified in South Africa.